Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

Clinical trial NCT05556720 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05556720
Sponsor: Monash University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Organ Transplantation Lymphoma, Non-Hodgkin Chronic Lymphocytic Leukemia Multiple Myeloma COVID-19 Vaccines

Start date: 2022-12-01
Primary completion: 2026-06-30
Enrollment: 960

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.